These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32895480)

  • 41. Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancer.
    Kitai H; Ebi H
    Small GTPases; 2017 Jul; 8(3):172-176. PubMed ID: 27392325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
    Zhang J; Zhang L; Su X; Li M; Xie L; Malchers F; Fan S; Yin X; Xu Y; Liu K; Dong Z; Zhu G; Qian Z; Tang L; Schöttle J; Zhan P; Ji Q; Kilgour E; Smith PD; Brooks AN; Thomas RK; Gavine PR
    Clin Cancer Res; 2012 Dec; 18(24):6658-67. PubMed ID: 23082000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT.
    Ryan MR; Sohl CD; Luo B; Anderson KS
    Mol Cancer Res; 2019 Feb; 17(2):532-543. PubMed ID: 30257990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Author Correction: Cardiac glycoside/aglycones inhibit HIV-1 gene expression by a mechanism requiring MEK1/2-ERK1/2 signaling.
    Wong RW; Lingwood CA; Ostrowski MA; Cabral T; Cochrane A
    Sci Rep; 2019 Dec; 9(1):18656. PubMed ID: 31796843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correction: CSN6-TRIM21 axis instigates cancer stemness during tumorigenesis.
    Qin B; Zou S; Li K; Wang H; Wei W; Zhang B; Xiao L; Choi HH; Tang Q; Huang D; Liu Q; Pan Q; Meng M; Fang L; Lee MH
    Br J Cancer; 2020 Sep; 123(6):1042-1044. PubMed ID: 32647365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer.
    Pan C; Yao G; Liu B; Ma T; Xia Y; Wei K; Wang J; Xu J; Chen L; Chen Y
    Cell Physiol Biochem; 2017; 43(1):339-352. PubMed ID: 28854421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correction: Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer.
    El-Kenawi A; Gatenbee C; Robertson-Tessi M; Bravo R; Dhillon J; Balagurunathan Y; Berglund A; Vishvakarma N; Ibrahim-Hashim A; Choi J; Luddy K; Gatenby R; Pilon-Thomas S; Anderson A; Ruffell B; Gillies R
    Br J Cancer; 2020 Mar; 122(7):1118. PubMed ID: 31937927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer.
    Malchers F; Dietlein F; Schöttle J; Lu X; Nogova L; Albus K; Fernandez-Cuesta L; Heuckmann JM; Gautschi O; Diebold J; Plenker D; Gardizi M; Scheffler M; Bos M; Seidel D; Leenders F; Richters A; Peifer M; Florin A; Mainkar PS; Karre N; Chandrasekhar S; George J; Silling S; Rauh D; Zander T; Ullrich RT; Reinhardt HC; Ringeisen F; Büttner R; Heukamp LC; Wolf J; Thomas RK
    Cancer Discov; 2014 Feb; 4(2):246-57. PubMed ID: 24302556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Author Correction: Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression.
    Fozzatti L; Alamino VA; Park S; Giusiano L; Volpini X; Zhao L; Stempin CC; Donadio AC; Cheng SY; Pellizas CG
    Sci Rep; 2019 Dec; 9(1):18772. PubMed ID: 31801959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Centchroman suppresses breast cancer metastasis by reversing epithelial-mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling.
    Khan S; Shukla S; Sinha S; Lakra AD; Bora HK; Meeran SM
    Int J Biochem Cell Biol; 2015 Jan; 58():1-16. PubMed ID: 25448414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
    Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
    Sci Rep; 2019 Dec; 9(1):18771. PubMed ID: 31801957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Author Correction: Caveolin-1 promotes invasion and metastasis by upregulating Pofut1 expression in mouse hepatocellular carcinoma.
    Zhang C; Huang H; Zhang J; Wu Q; Chen X; Huang T; Li W; Liu Y; Zhang J
    Cell Death Dis; 2019 Jul; 10(8):572. PubMed ID: 31358729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer.
    Middleton G; Fletcher P; Popat S; Savage J; Summers Y; Greystoke A; Gilligan D; Cave J; O'Rourke N; Brewster A; Toy E; Spicer J; Jain P; Dangoor A; Mackean M; Forster M; Farley A; Wherton D; Mehmi M; Sharpe R; Mills TC; Cerone MA; Yap TA; Watkins TBK; Lim E; Swanton C; Billingham L
    Nature; 2020 Sep; 585(7826):E21. PubMed ID: 32887973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes.
    Maoz M; Devir M; Inbar M; Inbar-Daniel Z; Sherill-Rofe D; Bloch I; Meir K; Edelman D; Azzam S; Nechushtan H; Maimon O; Uziely B; Kadouri L; Sonnenblick A; Eden A; Peretz T; Zick A
    Sci Rep; 2020 Feb; 10(1):3941. PubMed ID: 32109238
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Publisher Correction: The metabolite BH4 controls T cell proliferation in autoimmunity and cancer.
    Cronin SJF; Seehus C; Weidinger A; Talbot S; Reissig S; Seifert M; Pierson Y; McNeill E; Longhi MS; Turnes BL; Kreslavsky T; Kogler M; Hoffmann D; Ticevic M; da Luz Scheffer D; Tortola L; Cikes D; Jais A; Rangachari M; Rao S; Paolino M; Novatchkova M; Aichinger M; Barrett L; Latremoliere A; Wirnsberger G; Lametschwandtner G; Busslinger M; Zicha S; Latini A; Robson SC; Waisman A; Andrews N; Costigan M; Channon KM; Weiss G; Kozlov AV; Tebbe M; Johnsson K; Woolf CJ; Penninger JM
    Nature; 2019 Aug; 572(7769):E18. PubMed ID: 31363232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon.
    Rooney C; Geh C; Williams V; Heuckmann JM; Menon R; Schneider P; Al-Kadhimi K; Dymond M; Smith NR; Baker D; French T; Smith PD; Harrington EA; Barrett JC; Kilgour E
    PLoS One; 2016; 11(2):e0149628. PubMed ID: 26905262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correction: PPA1 promotes NSCLC progression via a JNK- and TP53-dependent manner.
    Luo D; Liu D; Shi W; Jiang H; Liu W; Zhang X; Bao Y; Yang W; Wang X; Zhang C; Wang H; Yuan L; Chen Y; Qu T; Ou D; Shen W; Yang S
    Oncogenesis; 2019 Dec; 8(12):75. PubMed ID: 31857572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Author Correction: Intravenous C16 and angiopoietin-1 improve the efficacy of placenta-derived mesenchymal stem cell therapy for EAE.
    Tian KW; Zhang YY; Jiang H; Han S
    Sci Rep; 2020 May; 10(1):8097. PubMed ID: 32393781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correction: PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice.
    Yin X; Hu L; Zhang Y; Zhu C; Cheng H; Xie X; Shi M; Zhu P; Zhao X; Chen W; Zhang L; Arakaki C; Hao S; Wang M; Cao W; Ma S; Zhang XB; Cheng T
    Bone Marrow Transplant; 2020 Jun; 55(6):1211-1212. PubMed ID: 31925343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.